Company / PP&E (Net)
Day One Biopharmaceuticals, Inc. PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.1M
FY2025
5-year range
$20.0K / $2.3M
FY2021-FY2025
Trend
-6.5%
vs FY2024
Sector context
#133 of 195
Health Care
What the data says
At $2M, Day One Biopharmaceuticals, Inc.'s pp&e (net) ranks #133 of 195 in the Health Care sector. Improved from $208,000 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +94.4%.
Improved from $208,000 to $2M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +374.4%
- 5-Year CAGR
- +94.4%
- 10-Year CAGR
- -
Sector benchmark
#133 of 195 in Health CareTop 68% of 195This company $2.1M Sector average $770.1M
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +94.4%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 6.5% year-over-year.
- Ranks #133 out of 195 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.1M | -6.5% |
| FY2024 | $2.3M | +998.6% |
| FY2023 | $208.0K | +940.0% |
| FY2022 | $20.0K | -64.9% |
| FY2021 | $57.0K | -26.0% |
| FY2020 | $77.0K | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026